Skip to main content
PMC home page
Gut logoLink to Gut
. 1989 Mar;30(3):361–366. doi: 10.1136/gut.30.3.361

Deposits of terminal complement complex (TCC) in muscularis mucosae and submucosal vessels in ulcerative colitis and Crohn's disease of the colon.

T S Halstensen 1, T E Mollnes 1, O Fausa 1, P Brandtzaeg 1
PMCID: PMC1378459  PMID: 2707635

Abstract

Extensively washed, ethanol fixed and paraffin embedded colonic specimens from 15 patients with ulcerative colitis (UC) and nine patients with Crohn's disease (CD) of the colon, ileal specimens from six patients with CD of the ileum, and histologically normal control specimens obtained from 10 patients operated for colonic carcinoma, were examined by immunohistochemistry with a monoclonal antibody specific for a neoepitope in the C9 part of the terminal complement complex (TCC). The submucosal blood vessels in inflammatory bowel disease (IBD) showed significantly more TCC positivity than the controls, and vascular TCC deposition was statistically related (p less than 0.001) to degree of inflammation. Five of the six ileal CD specimens contained likewise vascular TCC deposits. In addition, five UC specimens and one colonic CD specimen contained TCC-positive fibrils in the muscularis mucosae or submucosa. There was no significant difference in vascular TCC deposits between UC and CD. The results suggested that terminal complement activation takes place in the intestinal lesions of IBD.

Full text

PDF
362

Images in this article

363Fig. 1
on p.363
364Fig. 2
on p.364
364Fig. 3
on p.364

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler S., Baker P. J., Johnson R. J., Ochi R. F., Pritzl P., Couser W. G. Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest. 1986 Mar;77(3):762–767. doi: 10.1172/JCI112372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baklien K., Brandtzaeg P. Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon. Clin Exp Immunol. 1975 Nov;22(2):197–209. [PMC free article] [PubMed] [Google Scholar]
  3. Baklien K., Brandtzaeg P. Letter: Immunohistochemical localization of complement in intestinal mucosa. Lancet. 1974 Nov 2;2(7888):1087–1088. doi: 10.1016/s0140-6736(74)92198-9. [DOI] [PubMed] [Google Scholar]
  4. Ballard J., Shiner M. Evidence of cytotoxicity in ulcerative colitis from immunofluorescent staining of the rectal mucosa. Lancet. 1974 May 25;1(7865):1014–1017. doi: 10.1016/s0140-6736(74)90416-4. [DOI] [PubMed] [Google Scholar]
  5. Bhakdi S., Tranum-Jensen J. Membrane damage by complement. Biochim Biophys Acta. 1983 Aug 11;737(3-4):343–372. doi: 10.1016/0304-4157(83)90006-0. [DOI] [PubMed] [Google Scholar]
  6. Boom B. W., Out-Luiting C. J., Baldwin W. M., Westedt M. L., Daha M. R., Vermeer B. J. Membrane attack complex of complement in leukocytoclastic vasculitis of the skin. Presence and possible pathogenetic role. Arch Dermatol. 1987 Sep;123(9):1192–1195. [PubMed] [Google Scholar]
  7. Brandtzaeg P., Dale I., Fagerhol M. K. Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. I. Comparison with other leukocyte markers by paired immunofluorescence and immunoenzyme staining. Am J Clin Pathol. 1987 Jun;87(6):681–699. doi: 10.1093/ajcp/87.6.681. [DOI] [PubMed] [Google Scholar]
  8. Brandtzaeg P. Mucosal and glandular distribution of immunoglobulin components. Immunohistochemistry with a cold ethanol-fixation technique. Immunology. 1974 Jun;26(6):1101–1114. [PMC free article] [PubMed] [Google Scholar]
  9. Chao L. P., Steele J., Rodrigues C., Lennard-Jones J., Stanford J. L., Spiliadis C., Rook G. A. Specificity of antibodies secreted by hybridomas generated from activated B cells in the mesenteric lymph nodes of patients with inflammatory bowel disease. Gut. 1988 Jan;29(1):35–40. doi: 10.1136/gut.29.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cines D. B., Lyss A. P., Bina M., Corkey R., Kefalides N. A., Friedman H. M. Fc and C3 receptors induced by herpes simplex virus on cultured human endothelial cells. J Clin Invest. 1982 Jan;69(1):123–128. doi: 10.1172/JCI110422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dahlbäck K., Löfberg H., Dahlbäck B. Localization of vitronectin (S-protein of complement) in normal human skin. Acta Derm Venereol. 1986;66(6):461–467. [PubMed] [Google Scholar]
  12. Danis V. A., Harries A. D., Heatley R. V. Antigen-antibody complexes in inflammatory bowel disease. Scand J Gastroenterol. 1984 Jul;19(5):603–606. [PubMed] [Google Scholar]
  13. Das K. M., Sakamaki S., Vecchi M., Diamond B. The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: cellular localization of the antigen by using the monoclonal antibody. J Immunol. 1987 Jul 1;139(1):77–84. [PubMed] [Google Scholar]
  14. Falk R. J., Podack E., Dalmasso A. P., Jennette J. C. Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue. Am J Pathol. 1987 Apr;127(1):182–190. [PMC free article] [PubMed] [Google Scholar]
  15. Folkersen J., Søfeldt S., Svehag S. E. Application of electroblotting technique to studies of the intestinal antibody response to extractable fecal antigens. Scand J Gastroenterol. 1985 Mar;20(2):247–253. doi: 10.3109/00365528509089666. [DOI] [PubMed] [Google Scholar]
  16. Halstensen T. S., Mollnes T. E., Brandtzaeg P. Terminal complement complex (TCC) and S-protein (vitronectin) on follicular dendritic cells in human lymphoid tissues. Immunology. 1988 Oct;65(2):193–197. [PMC free article] [PubMed] [Google Scholar]
  17. Hartung H. P., Bitter-Suermann D., Hadding U. Induction of thromboxane release from macrophages by anaphylatoxic peptide C3a of complement and synthetic hexapeptide C3a 72-77. J Immunol. 1983 Mar;130(3):1345–1349. [PubMed] [Google Scholar]
  18. Hartung H. P., Hadding U., Bitter-Suermann D., Gemsa D. Stimulation of prostaglandin E and thromboxane synthesis in macrophages by purified C3b. J Immunol. 1983 Jun;130(6):2861–2865. [PubMed] [Google Scholar]
  19. Hodgson H. J., Potter B. J., Skinner J., Jewell D. P. Immune-complex mediated colitis in rabbits. An experimental model. Gut. 1978 Mar;19(3):225–232. doi: 10.1136/gut.19.3.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hänsch G. M., Seitz M., Martinotti G., Betz M., Rauterberg E. W., Gemsa D. Macrophages release arachidonic acid, prostaglandin E2, and thromboxane in response to late complement components. J Immunol. 1984 Oct;133(4):2145–2150. [PubMed] [Google Scholar]
  21. Kett K., Rognum T. O., Brandtzaeg P. Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn's disease of the colon. Gastroenterology. 1987 Nov;93(5):919–924. doi: 10.1016/0016-5085(87)90552-x. [DOI] [PubMed] [Google Scholar]
  22. Lauritsen K., Laursen L. S., Bukhave K., Rask-Madsen J. Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology. 1986 Oct;91(4):837–844. doi: 10.1016/0016-5085(86)90684-0. [DOI] [PubMed] [Google Scholar]
  23. Ligumsky M., Karmeli F., Sharon P., Zor U., Cohen F., Rachmilewitz D. Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine. Gastroenterology. 1981 Sep;81(3):444–449. [PubMed] [Google Scholar]
  24. MacKechnie H. L. The immunology of inflammatory bowel disease. Henry Ford Hosp Med J. 1982;30(1):25–32. [PubMed] [Google Scholar]
  25. Mollnes T. E., Lea T., Harboe M., Tschopp J. Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma. Scand J Immunol. 1985 Aug;22(2):183–195. doi: 10.1111/j.1365-3083.1985.tb01870.x. [DOI] [PubMed] [Google Scholar]
  26. Monteiro E., Fossey J., Shiner M., Drasar B. S., Allison A. C. Antibacterial antibodies in rectal and colonic mucosa in ulcerative colitis. Lancet. 1971 Feb 6;1(7693):249–250. doi: 10.1016/s0140-6736(71)90997-4. [DOI] [PubMed] [Google Scholar]
  27. Otto H. F., Gebbers J. O. The local immune response in ulcerative colitis. Pathol Res Pract. 1979 Dec;165(4):349–364. doi: 10.1016/s0344-0338(79)80029-1. [DOI] [PubMed] [Google Scholar]
  28. Rutherford B., Schenkein H. A. C3 cleavage products stimulate release of prostaglandins by human mononuclear phagocytes in vitro. J Immunol. 1983 Feb;130(2):874–877. [PubMed] [Google Scholar]
  29. Ryan U. S., Schultz D. R., Ruan J. W. Fc and C3b receptors on pulmonary endothelial cells: induction by injury. Science. 1981 Oct 30;214(4520):557–558. doi: 10.1126/science.6270789. [DOI] [PubMed] [Google Scholar]
  30. Schäfer H., Mathey D., Hugo F., Bhakdi S. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J Immunol. 1986 Sep 15;137(6):1945–1949. [PubMed] [Google Scholar]
  31. Stimler N. P., Bach M. K., Bloor C. M., Hugli T. E. Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin. J Immunol. 1982 May;128(5):2247–2252. [PubMed] [Google Scholar]
  32. Strober W., James S. P. The immunologic basis of inflammatory bowel disease. J Clin Immunol. 1986 Nov;6(6):415–432. doi: 10.1007/BF00915248. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES